Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer mortality, despite significant improvements in diagnostic imaging and operative mortality rates. The 5-year survival rate remains less than 5% because of microscopic or gross metastatic disease at time of diagnosis. The Cl...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Philip, Philip A., Mooney, Margaret, Jaffe, Deborah, Eckhardt, Gail, Moore, Malcolm, Meropol, Neal, Emens, Leisha, O'Reilly, Eileen, Korc, Murray, Ellis, Lee, Benedetti, Jacqueline, Rothenberg, Mace, Willett, Christopher, Tempero, Margaret, Lowy, Andrew, Abbruzzese, James, Simeone, Diane, Hingorani, Sunil, Berlin, Jordan, Tepper, Joel
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2009
Subjects:
Special Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7587401/
https://ncbi.nlm.nih.gov/pubmed/19858397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.9022
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items